Objectives. The objectives of this medico-legal case report were the following: 1) To present an example of a medico-legal problem that developed as a result of a decision to rotate a chronic pain patient (CPP) to methadone in order to taper the CPP from oxycodone; 2) To present both the plaintiff's and defendant's expert witnesses' opinions as to if and where the care of that patient fell below the "standard of medical care;" and 3) Based on these opinions, to develop some recommendations on how, in the future, pain medicine physicians and other physicians should proceed, in order to avoid allegations of breach of "standards of care" when using methadone.
Introduction

M
ethadone is a synthetic opioid of the diphenylpropylamine class [1, 2] . It has excellent oral bioavailability, low cost, extensive liver metabolization, no active metabolites, and is excreted mainly by the fecal route, therefore, it does not accumulate significantly in patients with renal impairment [2, 3] . Because of the above, and its long-half life that enables extended dosing intervals (daily or 2-3 times per day), it has been utilized as a maintenance drug for heroin addicts [1] [2] [3] [4] [5] and chronic pain patients [1, 5] . Methadone has also been used as a detoxification agent in detoxification protocols from other opioids [6, 7] .
However, methadone has a number of negative aspects, which have made its use difficult. First, there are large interindividual variations in the pharmacokinetics of methadone. It is characterized by a rapid distribution phase (half-life 2-3 hours) that is followed by a slow elimination phase. This elimination phase has been noted to vary from 4.2 to 130 hours in some patients. Thus, variations in the elimination phase could lead to accumulation toxicity in some patients [1] [2] [3] . In addition, methadone may interact with other drugs. These are drugs that can affect (inhibit or induce) the cytochrome P450 system, specifically the CYP3A4 isoenzyme system. Thus, inhibitors of 3A4, such as some selective serotonin reuptake inhibitors, have the potential to increase levels of methadone [3] . Methadone may also partially inhibit the CYP2D6 isoenzyme system, thus affecting levels of such drugs as dextromethorphan, codeine, hydrocodone, secondary tricyclics, haloperidol, phenothiazine, and beta-blockers [3] . These properties of methadone decreased the popularity of the drug in the 1980s and early 1990s [1, 4] .
Recently, however, the popularity of methadone for pain treatment has increased due to a number of converging scientific discoveries about methadone. In addition to opioid agonist activity, methadone has been noted to demonstrate a relatively potent N-methyl-D-aspartate (NMDA) receptor antagonism [3, 4] . Thus, methadone has been touted as having a potential role in opioid resistance and neuropathic pain [3] . For these types of problems and where uncontrollable side effects to other opioids occur, rotation to methadone from the current opioid has been advised [3] . A number of studies [8, 9] have demonstrated that rotation to methadone does indeed result in significant reduction in pain and/or reduction of side effects.
The case described below was that of a chronic pain patient rotated from controlled-release (CR) oxycodone to methadone for detoxification purposes. The rotation appeared to result in dire medical consequences, which then resulted in a medico-legal suit. Because this case highlights a number of issues with respect to methadone use and issues in detoxification, it is described below.
Case Report
Mr. X was a 35-year-old Caucasian male who arrived at a detoxification facility with the chief complaint of opioid addiction. His alleged medication use (per Mr. X) was as follows: oxycodone CR, 800 mg per day; oxycodone 5 mg/acetaminophen 500 mg, 70 tablets per day; hydrocodone 7.5 mg/acetaminophen 325 mg, 70 tablets per day; and alprazolam 2 mg, up to 12 tablets per day. Mr. X would take one of the three above opioids daily. Mr. X claimed that he was taking these doses for chronic low back pain that resulted from a motor vehicle accident 3 years previously. He was getting these medications from two physicians and claimed that he had last used medications approximately 48 hours previously. He was complaining of restlessness, shakiness, nausea, and abdominal cramping. His vital signs were stable, and his sensorium was clear at admission. He had been last detoxified 3 months previously, using methadone. There was a history of illicit drug use (crack cocaine and cannabinoids since adolescence and recently). On admission, he was placed on oxycodone CR 60 mg per day, oxycodone 5 mg/ acetaminophen 500 mg every 6 hours as needed, and alprazolam 2 mg three times a day by the oncall psychiatrist. These doses were chosen according to telephone information transmitted by the nursing staff.
Mr. X was evaluated the day of his admission by the family medicine doctor, who noted that he demonstrated withdrawal symptoms (diarrhea, cramps, gooseflesh, sweats) and assigned a diagnosis of opioid withdrawal. Approximately 24 hours after admission, Mr. X was evaluated by the psychiatrist who diagnosed opiate dependence. The psychiatrist then discontinued the oxycodone CR and placed Mr. X on a 5-day alprazolam and methadone taper. In addition, he ordered clonidine 0.1 mg twice a day and zolpidem 10 mg as needed, at bedtime. The first step of the methadone taper was 35 mg twice a day.
That day, Mr. X received 70 mg of methadone and 0.2 mg of clonidine in addition to 20 mg of oxycodone CR and 10 mg of zolpidem ( Figure 1 ). However, that night, at midnight, Mr. X was noted to be fully awake, not somnolent, and in no distress. Unfortunately, 2 hours later, Mr. X was found in the bathroom expired, lying in vomit. For a detailed timeline, please refer to Figure 1 .
Coroner autopsy results fixed the cause of death as asphyxia secondary to aspiration of gastric contents. Postexpiration laboratory results yielded the following information. Admission drug screen was positive for benzodiazepines and cocaine. Twentyhour postadmission drug screen was positive for benzodiazepines, cocaine, and opioids. Postmortem body fluid analysis yielded a methadone blood level of 0.81 mg/L (toxic levels are 2 mg/L and therapeutic levels are 0.1-0.4 mg/L) [10] .
Very soon after the death, a medical malpractice suit was filed against the addiction facility and the psychiatrist. We are only concerned with the medical malpractice aspects of this case. The plaintiff's expert witness noted a number of medical areas that she felt fell "below the standard." These are presented in Table 1 . The defendant's expert witness responded to these allegations as shown in the second column of what might be construed to be the current "standard of care" in reference to each allegation. The plaintiff's expert witness essentially alleged that Mr. X had expired from going into respiratory depression from a methadone overdose. The defendant's expert witness believed that Mr. X had died from aspiration secondary to vomiting. Vomiting could have been caused by the opioid itself (methadone, oxycodone), from opioid withdrawal, or from other reasons such as cocaine intoxication [11] . The most likely possibility, however, was opioid withdrawal. In a later deposition, the coroner indicated that, in her opinion, Mr. X did not die from a methadone overdose. The case was, therefore, settled for substantially less than policy limits.
Discussion
The nature of Mr. X's case and the subsequent comments of the expert witnesses bring to light a number of issues recently presented in the pain literature. These issues are now becoming important to patient care. In addition, Mr. X's case also highlights or illuminates other older issues, which have also been important to good patient care for many years. These issues are the following.
First, as pointed out by the plaintiff's expert witness, there is an expectation that physicians will see/evaluate patients before prescribing and that this will be done in a timely manner (allegation #1). As pointed out by the defendant's expert, in certain circumstances, such as prevention of withdrawal, this expectation is waived. This allegation is closely related to allegations #2 and #3.
Second, the plaintiff's expert raises a complex medico-legal clinical issue, that of whether drugdependent/intoxicated/abusing/addicted patients should be believed about their current drug use and whether clinical decisions should be based on It is standard in the community to prevent considered to be dangerous, it is the order to start opioids.
withdrawal and not let patients go into duty of the physician to try to prevent withdrawal and then treat the withdrawal. In discomfort associated with this addition, the observations of the family syndrome. medicine physician support the fact that Mr. X was in withdrawal at time +3 hours. 7. Psychiatrist had given enough Psychiatrist did not fall below the standard here. Pain physicians doing opioid oxycodone CR and oxycodone He chose to rotate Mr. X to methadone in order detoxification have the choice of to relieve withdrawal symptoms to detoxify Mr. X, using methadone. This is a which agent they will use in their and, therefore, should not have well-recognized detoxification protocol [6, 7] . detoxification protocol. For example, given methadone.
Mr. X could have been detoxified with oxycodone CR [6, 7] There is no evidence that Mr. X went into methadone overdose caused by respiratory depression. Mr. X was seen to be the overprescribing of awake and nonsomnolent 2 hours before death. methadone.
In addition, Mr. X was not found in bed, which would be expected if he became somnolent and then went into respiratory depression. Methadone level, although above therapeutic levels, was not within toxic range. Finally, the coroner did not identify the cause of death as related to methadone overdose.
Psychiatrist should have
Psychiatrist did not fall below the standard here. Sedative withdrawal is potentially switched patient to a long-acting There is no evidence in the chart that Mr. X dangerous [6, 7] . As such, patients benzodiazepine for went into a sedative withdrawal. Although with potential sedative withdrawal detoxification from alprazolam.
current literature recommends that patients should not be undermedicated. undergoing sedative detoxification should be transferred to a long-acting benzodiazepine, this is not considered mandatory [6, 7] . 14. Vomiting was caused by the Psychiatrist did not fall below the standard here. NA methadone and is implicated in Vomiting is associated with cocaine intoxication patient's death. [11] . In addition, vomiting is associated with opioid withdrawal and there is significant evidence that Mr. X was in opioid withdrawal at admission and on his first day. Opioid toxicologies support this opinion also (negative on admission and positive on second day). The opioid toxicologies are consistent with the history given by the patient. As Mr. X was tolerant to a significant amount of opioid, it is unlikely that he would develop vomiting secondary to the methadone, as patients tolerant to an qpioid are tolerant to the emetic effects of the drug.
the history that they provide. There is good study evidence [12] and important previous studies reviewed by Fishbain et al. [12] that indicate that a high percentage of these patients do not provide a correct drug history or a history that can be relied upon to make clinical decisions. This is aptly demonstrated by Mr. X's case, where, according to the history given and the calculated equivalencies, Mr. X could have been taking 1050 mg, 600 mg, or 233 mg of methadone per day. As such, the plaintiff's expert advocated discounting any presented history, allowing the patient to go into withdrawal, and basing treatment on urine toxicology results (allegations #4, #5, #6, #10, and #11). The defendant's expert disagreed with this position and advocated a preventative prompt approach to withdrawal treatment, which may have been based on information that may have been incomplete or unreliable. Even though opioid withdrawal is not considered to be dangerous, the literature advocates a preventative approach [6, 7] . This supported the position of the defendant's expert. As opioid withdrawal is not considered to be dangerous at first glance, there may be less medico-legal risk in the plaintiff's expert's approach. However, opioid withdrawal can produce nausea and, as such, could lead to aspiration, as in Mr. X's case. Thus, the senior author advocates the following approach when encountering the problem situation demonstrated by Mr. X. Treatment should not be withheld, and a preventative approach to withdrawal should be undertaken. However, before this is initiated, the pain physician should utilize all possible information sources before deciding on the prescription. These sources should be the following: The history presented by the patient; information from the pharmacy bottle(s); information from prescribing physicians; collateral information from significant others; and calculated equivalencies data. An attempt to tap these sources can be considered to be the current standard of care for this problem. Urine toxicologies, if available within a short period of time (hours), can be used as additional sources of information and can serve as a check on the patient's history. However, urine toxicologies are often unreliable [12] and, thus, may confuse the situation. The urine toxicology results should then be interpreted with caution in developing the detoxification protocol. At the present time, urine toxicology results are not the standard of care in developing a detoxification protocol and in preventing withdrawal. Overall, therefore, the defendant's expert's approach more closely follows what is the current "standard of care." Third, as indicated in Table 1 , the defendant's expert disagreed with all 14 falling below the standard of care allegations except perhaps allegations #8, #12, and #14. Although it is unlikely, as presented, that Mr. X died from methadone overdose, these allegations have some literature support. In calculating the equivalencies of methadone that Mr. X could tolerate, a ratio of 3 : 2 of morphine to methadone was used. This is a standard ratio found in textbooks. However, recent literature indicates that this ratio is incorrect and should be larger. It has been suggested that the calculated equianalgesic dose of methadone in methadone rotation should be reduced by 75-90% [13] . This relates to the greater-than-expected potency of methadone, potential accumulation of methadone [2, [13] [14] [15] , and the possible predisposition of patients previously exposed to high doses of opioids to methadone toxicity [3] . Keeping these difficulties in mind, a number of protocols for rotation to methadone have been developed [2] [3] [4] 14] . The literature indicates that clinicians rotating patients to methadone from another opioid should use a much lower equianalgesic ratio or one of the suggested rotation protocols. This could now be considered to be the "standard of care." It is to be noted that one of those protocols [3] stops the original opioid and immediately rotates to methadone. Thus, allegation #9 of the plaintiff's expert is not viable as, according to that study, the psychiatrist did not "fall below the standard of care" here.
The final point relates to allegation #7. Here, the plaintiff's expert questioned why the patient was rotated to methadone from oxycodone CR if his withdrawal symptoms were relatively well controlled. As indicated by the defendant's expert, rotation to methadone was done in order to detoxify Mr. X. As this is an acceptable detoxification strategy [6, 7] , this allegation is also not viable. As such, the defendant did not fall below the standard of care here either. However, there are other detoxification strategies [6, 7] , such as detoxifying with the opioid of abuse (oxycodone CR), which could have been chosen. In light of what was presented above for potential difficulties with methadone, perhaps an alternate detoxification protocol should have been chosen, decreasing the possibility of problems.
A final issue relates to whether the psychiatrist made his clinical decision based on medical system administrative pressures. It is to be noted that 200 Fishbain et al.
detoxification facilities are now at increased pressure from health insurers and HMOs to detoxify patients in the shortest period of time possible. Presently, some HMOs allow only 3 days to complete opioid detoxification, while others allow 5 days. Alcohol/sedative detoxification is now usually limited to less than 1 week. In this case, the psychiatrist placed Mr. X on a 5-day methadone and alpralozam taper. As such, this choice may have been dictated by the administrative pressure described above. It is to be noted that withdrawal is generally thought to be preventable if the daily decrease in medication does not exceed 50% of the previous day's dosage [16] . However, in the first author's experience, such daily decreases invariably lead to the development of significant withdrawal symptoms, with patients experiencing substantial difficulties. In addition, it is difficult to complete detoxification in 5 days even using the 50% decrease per day guideline if the patient begins detoxification from a large daily dose of opioid. Thus, these artificial administrative guidelines for length of detoxification treatment limit physicians' options with patients taking large doses of drugs. In addition, such administrative guidelines force physicians working in this area to proceed with detoxification at a rate that could lead to significant withdrawal in these patients and, thus, increased risk of liability. As a result of this pressure, rapid and ultrarapid (operative) [16] detoxification protocols have been developed. Chronic pain patients who are dependent/addicted to opioids or other drugs present the dual problem of chronic pain and drug dependence/addiction. According to the senior author's experience and the current literature [17] , these patients are generally difficult to detoxify successfully unless concomitant pain treatment is provided. As such, it is difficult to detoxify these patients in addiction facilities where pain treatment is not provided. Ideally the patient should be detoxified, if necessary, in pain facilities. Knowledge of the above issues can help physicians make decisions about detoxification that are not influenced by administrative pressure.
Conclusion
Pain physicians should proceed with caution in rotating to methadone. Such rotation should either proceed very slowly or utilize an accepted/ published rotation protocol.
